GlassScriptPhysician profile
Debra Gilhooly
NPI 1023222536
$6,186.64
in general payments reported to CMS, 2019-2025
24 companies · $638 in 2025
The $638 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,154 · 2022: $1,781 · 2023: $1,835 · 2024: $778 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,158 · Education: $93.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,157.80 |
| Education | $93.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $891.48 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $808.83 | 2021-2023 | |
| Exeltis, USA INC. | $804.91 | 2021-2025 | Slynd, Nuvessa, Nuvessa |
| Organon LLC | $660.65 | 2021-2023 | Nexplanon |
| Pfizer INC. | $507.13 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $318.25 | 2021-2025 | |
| Astellas Pharma US INC | $251.31 | 2023-2025 | Veozah |
| Avion Pharmaceuticals | $232.03 | 2021-2023 | Balcoltra |
| Millicent US INC | $216.37 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Exact Sciences Corporation | $210.84 | 2023-2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $196.81 | 2022 | |
| Therapeuticsmd, INC. | $189.86 | 2021-2022 | |
| Agile Therapeutics, INC. | $154.65 | 2021-2024 | Twirla |
| Evofem Biosciences, INC. | $132.69 | 2021-2024 | Phexxi |
| Scynexis, INC. | $109.67 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $104.12 | 2024-2025 | Zurzuvae |
| Urovant Sciences INC | $80.75 | 2022 | |
| Merck Sharp & Dohme LLC | $80.55 | 2021 | |
| Shield Therapeutics INC | $62.97 | 2024 | |
| Coopersurgical, INC. | $55.24 | 2023-2025 | Summit Doppler, Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $40.13 | 2021 | |
| Baxter Healthcare | $33.16 | 2025 | Perclot |
| Lupin INC. | $22.93 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Gilhooly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.